Listen to The Lancet Gastroenterology & Hepatology
Science & Medicine
Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.
Paediatric inflammatory bowel disease
Transplanting hepatitis C-infected hearts
Primary anastomosis as a treatment for diverticulitis
Faecal microbiota transplantation in IBS
Treating faecal incontinence in women
Viral hepatitis in children & adolescents
Whole-body MRI: the STREAMLINE trials
A new drug for short bowel syndrome
Acute hepatitis C
Epidemiology of chronic liver disease
Viral hepatitis in migrant populations
DAA treatment for hepatitis C among people who inject drugs
Pancreatic cancer treatment
UDCA Response Score
Global prevalence, treatment, and prevention of hepatitis B virus infection
Neoplasia detection in ulcerative colitis
Functional dyspepsia
Can DAA therapy for HCV reactivate HBV in coinfected patients?
Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018
Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
NASACast Video
Mysteries Abound